epsilon-hydroxynorleucine, (l)-isomer and B-Cell Lymphoma

epsilon-hydroxynorleucine, (l)-isomer has been researched along with B-Cell Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bendaoud, B; Berthou, C; Cornec, D; Hutin, P; Jamin, C; Pers, JO; Querellou, S; Renaudineau, Y; Tempescul, A; Youinou, P	1

Other Studies

1 other study(ies) available for epsilon-hydroxynorleucine, (l)-isomer and B-Cell Lymphoma

Article	Year
Identification of patients with indolent B cell lymphoma sensitive to rituximab monotherapy. Annals of hematology, 2012, Volume: 91, Issue:5 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; B-Cell Activating Factor; Complement C1q; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Norleucine; Polymorphism, Genetic; Positron-Emission Tomography; Prognosis; Receptors, IgG; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden	2012

Article

Year

Identification of patients with indolent B cell lymphoma sensitive to rituximab monotherapy.

Annals of hematology, 2012, Volume: 91, Issue:5

Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; B-Cell Activating Factor; Complement C1q; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Norleucine; Polymorphism, Genetic; Positron-Emission Tomography; Prognosis; Receptors, IgG; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden

2012